Dr. Silverman comments on July 11 AV-45 clinical presentation at the International Conference on Alzheimer’s Disease (ICAD)
July 11, 2010Daniel Silverman, MD, PhD, Director, UCLA Geffen School of Medicine, Brain Imaging Clinic comments on newest advances in diagnosing Alzheimer’s disease (AD) based on the July 11 AV-45 clinical presentation at ICAD. His team is presenting results of their current research using FDG-PET brain imaging and NeuroQ. The poster titled “Clinical and quantitative fluorodeoxyglucose positron emission tomography in pre- and symptomatic persons inheriting familial Alzheimer's disease mutations," will be presented Monday, Jul 12, at 11:30 AM - 1:00 PM (HST). As the head of the Neuronuclear Imaging Section at the David Geffen School of Medicine at UCLA, Dr. Silverman is an internationally known researcher, specializing in nuclear medicine imaging studies for the improved diagnosis and treatment of many types of dementia, including AD.